Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Female researcher in lab with pipette.

    Nuplazid Submitted to FDA for Treating Psychosis in People with Dementia

    Nuplazid, approved to treat psychosis in people with Parkinson’s, now is at the FDA for potential expanded use to treat psychosis in people with dementia.
    Learn more

  • BEAT PD DREAM Challenge

    MJFF and Sage Bionetworks Announce Winners of the BEAT-PD DREAM Challenge

    MJFF and Sage Bionetworks announce the winners of the BEAT-PD DREAM Challenge,
    Learn more

  • AAN Science Highlights images of a phone and computer screen

    2020 Science Highlights from the American Academy of Neurology

    In substitution of its annual meeting, the American Academy of Neurology (AAN) is sharing scientific presentations and presenting research online.
    Learn more

  • Well plate

    With Foundation Support, New Drugs Are Moving Closer to Market

    One of the most vexing aspects of Parkinson’s disease — to patients, clinicians and researchers — is its tremendous variability.
    Learn more

  • Fox Insight from Home.jpg

    Fox Insight Brings Research to You, at Home

    When it comes to understanding Parkinson’s disease (PD) and prioritizing patient needs, it’s vital to integrate the perspectives of people living with the disease.
    Learn more

  • following PD pipeline.jpg

    Following the Parkinson’s Pipeline Toward Cures

    The Michael J. Fox Foundation (MJFF) is tracking the progress surrounding therapies in our priority programs: alpha-synuclein, LRRK and GBA.
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.